Saluda Medical, Inc. (ASX: SLD) - Share Price
- Current share price for SLD : $0.645
Saluda Medical, Inc. (SLD) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a U.S.-based, commercial-stage medical device company initially founded in Australia. The Company is focused on developing treatments for chronic neurological conditions using our novel neuromodulation platform grounded in over 15 years of research and development.
SLD General Information +
| ASX Code | SLD |
| Website | http://www.saludamedical.com |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 162 |
| SLD Share Price | $0.645 |
| Day High | $0.645 |
| Day Low | $0.575 |
| Last Close | $0.645 |
| SLD Share Price Movement | - ( No change ) |
Prices as at 16:40, 10 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Saluda Medical, Inc. (SLD) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Saluda Medical, Inc. (SLD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Saluda Medical, Inc. (SLD) price-sensitive announcements
SLD - Quarterly Activities/Appendix 4C Cash Flow Report
Saluda Medical, Inc. reported strong financial results for Q4 FY26, surpassing its full-ye
Saluda Medical, Inc. (SLD)
29 Jul 2026 | 8:31 AM
29 Jul 2026 | 8:31 AM
SLD - SLD Receives FDA Approval for CAP24 Surgical Paddle Lead
Saluda Medical, Inc. has received FDA approval for its new CAP24 surgical paddle lead, all
Saluda Medical, Inc. (SLD)
30 Jun 2026 | 9:29 AM
30 Jun 2026 | 9:29 AM
SLD - Quarterly Activities/Appendix 4C Cash Flow Report
Saluda Medical, Inc. has reported strong commercial progress in Q3 FY26, with significant
Saluda Medical, Inc. (SLD)
30 Apr 2026 | 8:17 AM
30 Apr 2026 | 8:17 AM
SLD - Update - S&P DJI March 2026 Rebalance of the All Ordinaries
On March 10, 2026, S&P Dow Jones Indices announced the quarterly rebalance of the All Ordi
Saluda Medical, Inc. (SLD)
10 Mar 2026 | 5:28 PM
10 Mar 2026 | 5:28 PM
Saluda Medical, Inc. (SLD) Recent ASX Announcements
SLD Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$227.94 | -$90.40 | 54.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$147.69 | -$58.60 | 6.20% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$139.01 | -$55.20 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
SLD Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| 4DMedical Limited (4DX) | $2,530M | 0.3304 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $18,395M | 0.3919 | 0.2545 | 0.2962 | 159.9273 | 127.4833 | 98.3522 | 0.31% | 0.40% | 0.52% |
| Saluda Medical, Inc. (SLD) | $151M | 0.5433 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
SLD Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 0.73 | 0.00 |
| Market | 0.31 | 13.10 | 1.15 | 0.69 |
| Sector | 0.73 | 19.20 | 1.65 | 1.92 |
SLD Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Barry John Regan | Chief Executive Officer, President, Executive Director | 14 Jul 2025 |
| Mr Douglas Evan Godshall | Non-Executive Chairman, Non-Executive Director | 15 Jun 2021 |
| Ms Catherine Brighid Livingstone | Non-Executive Director | 5 Feb 2013 |
| Dr Geoffrey Edward Duncan Brooke | Non-Executive Director | 20 Oct 2020 |
| Mr Robert Carrington Faulkner | Non-Executive Director | 28 Jun 2019 |
| Mr Robert Jon Palmisano | Non-Executive Director | 13 Apr 2022 |
| Mr Quentin Blackford | Non-Executive Director | 1 Dec 2025 |
Saluda Medical, Inc. (SLD) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|
See all changes in directors' interest & trades for Saluda Medical, Inc. (SLD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
SLD Management
| Name | Position |
|---|---|
| Kristin Caplice | Company Secretary |
SLD Calendar of Events
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
